You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

darolutamide

Showing 51 - 65 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in United States (Relugolix, Leuprolide Acetate)

Recruiting
  • Prostate Cancer
  • Tucson, Arizona
  • +7 more
Feb 1, 2023

Preferences for Treatment of mPC in Hong Kong:Discrete Choice

Recruiting
  • Prostate Cancer
    • Sha Tin, Hong Kong
      Prince of Wales Hospital
    Mar 14, 2023

    Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

    Enrolling by invitation
    • Castration-resistant Prostate Cancer
    • Wuxi, Jiangsu, China
      Jiangnan University
    Sep 18, 2022

    Prostatic Tumors Trial in Mannheim (Dabigatran etexilate, Midazolam, BAY1841788 (darolutamide))

    Completed
    • Prostatic Neoplasms
    • Dabigatran etexilate
    • +2 more
    • Mannheim, Baden-Württemberg, Germany
      CRS Clinical-Research-Services Mannheim GmbH
    Nov 5, 2018

    Metastatic Castration Resistant Prostate Cancer Trial in Switzerland, United Kingdom (AZD5069, Enzalutamide 40 MG)

    Active, not recruiting
    • Metastatic Castration Resistant Prostate Cancer
    • Bellinzona, Switzerland
    • +3 more
    Mar 18, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

    Terminated
    Has Results
    • Metastatic Castration-resistant Prostate Cancer
    • Avelumab
    • 2nd generation ADT (abiraterone or enzalutamide)
    • New Orleans, Louisiana
      Tulane University School of Medicine
    Apr 6, 2022

    Prostate Cancer Trial in Québec (Enzalutamide capsule)

    Recruiting
    • Prostate Cancer
    • Enzalutamide capsule
    • Québec, Canada
      CHU de Québec-Université Laval
    Mar 29, 2022

    Prostate Cancer, Stereotactic Body Radiation Therapy Trial (SBRT, STANDARD OF CARE)

    Not yet recruiting
    • Prostate Cancer
    • Stereotactic Body Radiation Therapy
    • SBRT
    • STANDARD OF CARE
    • (no location specified)
    Jan 25, 2022

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Bellinzona, London Borough of Sutton (Enzalutamide 40mg,

    Recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Enzalutamide 40mg
    • +4 more
    • Bellinzona, Switzerland
    • +1 more
    Nov 6, 2023

    Predictive fActors for toleraNce to Taxane Based CHemotherapy In

    Completed
    • Elderly Patients
    • Metastatic Prostate Cancer
    • Taxane chemotherapy
    • Florence, Italy
      AOU Careggi Radiation Oncology Unit
    Jul 21, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Laboratory Biomarker Analysis
    • +3 more
    • La Jolla, California
    • +21 more
    Dec 2, 2022

    Progressive Metastatic Castrate-Resistant Prostate Cancer Trial in Worldwide (AZD4635, Durvalumab, Cabazitaxel)

    Active, not recruiting
    • Progressive Metastatic Castrate-Resistant Prostate Cancer
    • Sacramento, California
    • +15 more
    Mar 22, 2022

    Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

    Recruiting
    • Metastatic Prostate Cancer
    • Prostate Adenocarcinoma
    • Tucson, Arizona
    • +259 more
    Oct 19, 2022

    Pharmacokinetics, Hepatic Insufficiency, Renal Insufficiency Trial in Kiel, Lübeck (BAY1841788)

    Completed
    • Pharmacokinetics
    • +2 more
    • Kiel, Schleswig-Holstein, Germany
    • +1 more
    Jan 4, 2019

    Biological Availability Trial in Berlin (BAY1841788 (ODM-201), Itraconazole, Rifampicin)

    Completed
    • Biological Availability
    • BAY1841788 (ODM-201)
    • +2 more
    • Berlin, Germany
      CRS Clinical Research Services Berlin GmbH
    Jul 27, 2018